Aravind Subramanian

Head of Digital & Technology Platform
Aravind Subramanian

Prior to Dewpoint, Aravind trained at the Broad Institute of MIT and Harvard where he held roles of increasing responsibility, most recently as Director, Computational R&D.

Aravind’s research at the Broad Institute focused on technologies for generating large-scale perturbational datasets and their computational analysis.

Over the past decade, Aravind’s team has generated several large perturbation datasets by treating cultured human cells with small-molecule and biological agents.

These data, coupled with powerful pattern recognition algorithms, are made available in a popular public resource called the Connectivity Map and are routinely used by drug hunters to understand mechanisms of action of small-molecules, functionally annotate disease genes, and inform clinical studies.

Follow Aravind on LinkedIn

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
© 2019-2023 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science